Stock CTXR CITIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Citius Pharmaceuticals, Inc.

Equities

CTXR

US17322U2078

Delayed Nasdaq
Other stock markets
 11:20:46 2024-05-03 EDT 		5-day change 1st Jan Change
0.715 USD +1.13% Intraday chart for Citius Pharmaceuticals, Inc. +7.55% -5.49%
04-26 Citius Pharmaceuticals Launches $15 Million Offering MT
04-11 Citius Pharmaceuticals, Inc. Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CTXR Stock
  4. Revisions Citius Pharmaceuticals, Inc.